ARMATA PHARMACEUTICALS, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)

Item 2.02Results of Operations and Financial Condition.

On March 16, 2023, Armata Pharmaceuticals, Inc. (the "Company") announced its financial results for the three months and full fiscal year ended December 31, 2022, in the press release furnished hereto as Exhibit 99.1.

The information in this Item 2.02 and the attached Exhibit 99.1 is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in this Item 2.02 and the attached Exhibit 99.1 shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended.

Item 9.01Financial Statements and Exhibits.

(d)Exhibits.

Exhibit

No. Description

99.1 Press Release, dated March 16, 2023.

104 Cover Page Interactive Data File (embedded within Inline XBRL document).

© Edgar Online, source Glimpses